CHICAGO, March 22, 2021 /PRNewswire/ — According to the new market research report “Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs) – Global Forecast to 2026″, published by MarketsandMarkets™, the market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period.
Browse in-depth TOC on “Microcarrier Market”
349 – Tables
37 – Figures
291 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=139831731
The Rising demand for cell-based vaccines, technological advancements, investments for cell and gene research, and growing preference for single-use technologies are the key factors supporting the growth of the market. However, the high cost of cell biology research, limitations in the production of high-density, and microcarrier-cell detachments issues are expected to hinder the overall growth rate.
Consumables accounted for the largest share of microcarriers market
Based on product, the market is segmented into consumables and equipment. Consumables dominated the market in 2020. The large share of this segment can be attributed to recent product launches and repeated purchase of high amount of media for various applications.
Biopharmaceutical Production segment accounted for the largest share of…
